Status:
COMPLETED
COVID-19 Surveillance Based on Smart Wearable Device
Lead Sponsor:
Peking University First Hospital
Conditions:
COVID-19
Eligibility:
All Genders
18-75 years
Brief Summary
This is a prospective, multi-center cohort study. 200 subjects with COVID-19will be included . Wearable device's physiological parameters and clinical data will be continually collected , the investig...
Detailed Description
This is a prospective cohort study. 200 subjects aged 18～75y with asymptomatic, mild, general-type COVID-19 will be recruited. The physiological parameters of wearable devices, including heart rate, s...
Eligibility Criteria
Inclusion
- Age between 18 and 75 years(both 18 and 75), either gender;
- At the time of enrollment, patients with novel coronavirus infection meeting the criteria of The New Coronavirus Pneumonia Diagnosis and Treatment Program (Seventh Edition)
- Able to engage in daily activities;
- Willing to participate in this research and willing to follow the research program, with the ability to sign informed consent;
- having mobile communication equipment which can install APP of wearable device.
Exclusion
- Wear time of wearable devices \<50% during the whole study period
- Wearable devices have faults, missing signals or errors throughout the study period, resulting in the proportion of analyzable information \<50%
- Patients with incomplete outpatient and inpatient information and missing core information such as hospitalization / discharge time, symptoms, laboratory examination, disease progress record, etc.
- Patients with serious underlying diseases (including serious mental diseases, mental disorders, nervous system diseases, malignant tumors, chronic liver diseases, heart failure, autoimmune diseases, chronic kidney diseases), or life expectancy less than 6 months
- Unable to take care of themselves in daily life, unable to cooperate with medical history and data collection
- participating in other clinical trials;
- Pregnant women, women in puerperium
Key Trial Info
Start Date :
August 2 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 15 2021
Estimated Enrollment :
103 Patients enrolled
Trial Details
Trial ID
NCT04459637
Start Date
August 2 2020
End Date
April 15 2021
Last Update
March 28 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking University First Hospital
Beijing, Beijing Municipality, China, 100034